Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the best CRISPR stocks to buy. Citizens JMP reaffirmed its Market ...

Dallas Cowboys Cheerleaders,' fifth-year veteran and group leader Armani Latimer announced her retirement from the team. Here ...

House of Lords votes to block expulsion of hereditary peers - Peers supported an amendment to the House of Lords (Hereditary ...

Using 400 real-world patient cases, the CARE platform correctly classified 99.5 percent of cases according to NCCN guidelines ...

Lords reform task force proposed amid moves to oust hereditary peers - Concerns were raised that a select committee might be ...

The House of Lords (hereditary peers) bill does one simple thing: remove the remaining hereditary peers from membership of ...

Melanin can either protect or worsen hereditary hearing loss depending on genetic context, as reported by researchers from ...

Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which ...

CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.jpcc.7b06330. Experimental methods, synthesis, and characterization of P n DPF; CCDC numbers ...

BioCryst sells European Orladeyo rights to Neopharmed for up to $264 million, plans to eliminate term debt and boost long-term cash position.

BioCryst on Friday said it will receive an initial $250 million from Italian pharmaceutical company Neopharmed Gentili for the European assets and rights related to Orladeyo, along with up to $14 ...